Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(37.5%)

Phase 1

2(25.0%)

Phase 3

1(12.5%)

Early Phase 1

1(12.5%)

Phase 2

1(12.5%)

8Total

N/A(3)

Phase 1(2)

Phase 3(1)

Early Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05920798Phase 1Recruiting

Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Role: collaborator

NCT05108714Not ApplicableCompleted

Intradermal Lidocaine Via MicronJet600 Microneedle Device

Role: collaborator

NCT04393168Phase 1Completed

Proof-of-concept Study of LymphMonitor 1.0 to Assess the Lymphatic Vessel Function

Role: collaborator

NCT01686503Phase 2Completed

Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects

Role: collaborator

NCT01813604Phase 3Completed

Immunogenicity of Inactivated and Live Polio Vaccines

Role: collaborator

NCT00558649Not ApplicableCompleted

A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines

Role: lead

NCT00539084Not ApplicableCompleted

A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia

Role: lead

NCT00602914Early Phase 1Completed

A Pilot Study to Assess the Safety, PK and PD of Insulin Injected Via MicronJet or Conventional Needle

Role: lead

All 8 trials loaded